Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study


Akgun Z., Saglam S., Yucel S., Gural Z., Balik E., Cipe G., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, ss.751-756, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 74 Konu: 4
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s00280-014-2558-x
  • Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Sayfa Sayısı: ss.751-756

Özet

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.